Gastroesophageal reflux disease (GERD) is a human condition. Refer to the extract below from JW Peptide Preset frequency PDF which contains over 2,000 human conditions.
Quantum entanglement frequencies are used for any person or pet regardless of their location on earth. This method is used with a DNA sample such as a small piece of finger or toe nail.
The Remote mode with the Spooky2 rife device applies frequencies at any distance using the recipient’s DNA to treat people. It uses the principles of quantum physics and the antenna properties of DNA to transmit through nonlocal space.
Modern physicists named it “Quantum Entanglement.” To put it simply, it means that if any part of a single system is removed from that system to a different location, any action performed on the part will also be instantaneously performed on the parent system and vice versa.
Remote treatments can fit perfectly into your busy lifestyle. When you’re doing treatments with Remote, you don’t have to be in the same room or in the same country. Only your DNA is needed in the treatments.
Remote mode can be used to deliver Peptide presets.
I help people with chronic long term health issues who are receiving no results from their current treatment modalities. I help to overcome their issues.
Peptide Presets – A New Wellness and Healing Era for any Human Condition.
I have available over 2,000 human conditions that I can possibly help you with.
Find out more about Peptide Presets
Find out how the Holistic Wellness Frequency Program works – created by Dr Susan Grace.
My services are intended to support general wellbeing and are not a substitute for professional medical diagnosis or treatment.
Gastroesophageal reflux disease (GERD) – Peptide Presets
Below is an extract from JW Peptide Preset frequency PDF which contains over 2,000 human conditions.
Gastroesophageal reflux disease (GERD) involves chronic regurgitation of gastric contents into the oesophagus, leading to mucosal damage, inflammation, barrier dysfunction, and symptoms such as heartburn and epigastric pain. The proposed polypeptides target key mechanisms identified in literature, including inflammation, mucosal integrity, motility, and acid exposure.
- Inflammatory and pain modulation: Bombesin – Attenuates oxidative stress, inflammatory markers, and epigastric pain in GERD models.
- Mucosal trophic protection: GLP-2 – Provides trophic support and anti-inflammatory effects to repair damaged oesophageal epithelium.
- Innate antimicrobial defence: Human Beta-Defensin 2 – Strengthens epithelial barrier function diminished in GERD.
- Inflammation resolution: Annexin_A1_Ac2-26 – Promotes pro-resolving pathways to reduce persistent mucosal inflammation.
- Neuroinflammatory reduction: ARA-290 – Reduces tissue hypersensitivity and inflammatory pain signals.
- Gastric prokinetic activity: GHRP-6 – Enhances gastric emptying via ghrelin receptor agonism to decrease reflux risk.
- Acid secretion control: Secretin – Inhibits gastrin release and supports bicarbonate-mediated neutralization.
- Cytokine suppression: KPV – Potent short peptide inhibition of inflammatory cytokines in mucosa.
- Cathelicidin protection: LL-37 – Broad-spectrum antimicrobial action to prevent barrier-compromising infections.
- Postprandial regulation: Pramlintide – Modulates gastric emptying and secretion to limit acid exposure.
- Sphincter and healing support: BPC-157 – Increases lower oesophageal sphincter pressure and accelerates esophagitis healing.
- Barrier reinforcement: EsoBarrier-1 – Designed amphipathic cationic helical peptide for enhanced antimicrobial and structural barrier stabilization.
Peptides
Peptide 1: Bombesin (real) for Inflammatory and pain modulation
Peptide 2: GLP-2 (real) for Mucosal trophic protection
Peptide 3: Human Beta-Defensin 2 (real) for Innate antimicrobial defence
Peptide 4: Annexin_A1_Ac2-26 (real) for Inflammation resolution
Peptide 5: ARA-290 (real) for Neuroinflammatory reduction
Peptide 6: GHRP-6 (real) for Gastric prokinetic activity
Peptide 7: Secretin (real) for Acid secretion control
Peptide 8: KPV (real) for Cytokine suppression
Peptide 9: LL-37 (real) for Cathelicidin protection
Peptide 10: Pramlintide (real) for Postprandial regulation
Peptide 11: BPC-157 (real) for Sphincter and healing support
Peptide 12: EsoBarrier-1 (designed) for Barrier reinforcement